Cargando…

Conocimientos acerca del tratamiento con warfarina en pacientes con fibrilación auricular o portadores de válvulas protésicas mecánicas

OBJECTIVE: To determine the degree of knowledge about warfarin treatment in patients with atrial fibrillation or with mechanical prosthetic valves. MATERIALS AND METHODS: Descriptive, observational, cross-sectional study. The OAK test was applied to all adult patients with a diagnosis of atrial fibr...

Descripción completa

Detalles Bibliográficos
Autores principales: Vásquez Ortiz, Lady Rojana, Díaz Seijas, Deysi, Gordillo Campos, Natalia Emilia, Aguilar Alban, Ana Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Nacional Cardiovascular - INCOR 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284579/
https://www.ncbi.nlm.nih.gov/pubmed/37351016
http://dx.doi.org/10.47487/apcyccv.v3i4.256
_version_ 1785061433458819072
author Vásquez Ortiz, Lady Rojana
Díaz Seijas, Deysi
Gordillo Campos, Natalia Emilia
Aguilar Alban, Ana Elizabeth
author_facet Vásquez Ortiz, Lady Rojana
Díaz Seijas, Deysi
Gordillo Campos, Natalia Emilia
Aguilar Alban, Ana Elizabeth
author_sort Vásquez Ortiz, Lady Rojana
collection PubMed
description OBJECTIVE: To determine the degree of knowledge about warfarin treatment in patients with atrial fibrillation or with mechanical prosthetic valves. MATERIALS AND METHODS: Descriptive, observational, cross-sectional study. The OAK test was applied to all adult patients with a diagnosis of atrial fibrillation or with mechanical prosthetic valves treated with warfarin, who attended the hematology consultation from May 17 to November 10, 2022, at the "Instituto Nacional Cardiovascular Carlos Alberto Peschiera Carrillo". RESULTS: A total of 150 patients participated, 64% were male, with a mean age of 60.3 ± 15 years, 45.3% with a diagnosis of atrial fibrillation and 54.7% with mechanical prosthetic valves. The mean OAK test score was 44.4% (8.4/19), only 6% (n=9) achieved a satisfactory score ≥75.0%, the percentage of correct answers according to dimensions was: 68 % in forms of use, 39.3% in interactions and complications and 41.1% in INR control. A 40.7% did not understand the meaning of the term INR and 81.3% did not know their optimal values. CONCLUSIONS: The patient’s degree of knowledge about warfarin treatment was inadequate; both in its use, interactions and complications. Considering that it is a difficult drug to use, due to its narrow therapeutic window and its multiple interactions, inadequate knowledge of its use may contribute to inappropriate anticoagulation.
format Online
Article
Text
id pubmed-10284579
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Instituto Nacional Cardiovascular - INCOR
record_format MEDLINE/PubMed
spelling pubmed-102845792023-06-22 Conocimientos acerca del tratamiento con warfarina en pacientes con fibrilación auricular o portadores de válvulas protésicas mecánicas Vásquez Ortiz, Lady Rojana Díaz Seijas, Deysi Gordillo Campos, Natalia Emilia Aguilar Alban, Ana Elizabeth Arch Peru Cardiol Cir Cardiovasc Artículo Original OBJECTIVE: To determine the degree of knowledge about warfarin treatment in patients with atrial fibrillation or with mechanical prosthetic valves. MATERIALS AND METHODS: Descriptive, observational, cross-sectional study. The OAK test was applied to all adult patients with a diagnosis of atrial fibrillation or with mechanical prosthetic valves treated with warfarin, who attended the hematology consultation from May 17 to November 10, 2022, at the "Instituto Nacional Cardiovascular Carlos Alberto Peschiera Carrillo". RESULTS: A total of 150 patients participated, 64% were male, with a mean age of 60.3 ± 15 years, 45.3% with a diagnosis of atrial fibrillation and 54.7% with mechanical prosthetic valves. The mean OAK test score was 44.4% (8.4/19), only 6% (n=9) achieved a satisfactory score ≥75.0%, the percentage of correct answers according to dimensions was: 68 % in forms of use, 39.3% in interactions and complications and 41.1% in INR control. A 40.7% did not understand the meaning of the term INR and 81.3% did not know their optimal values. CONCLUSIONS: The patient’s degree of knowledge about warfarin treatment was inadequate; both in its use, interactions and complications. Considering that it is a difficult drug to use, due to its narrow therapeutic window and its multiple interactions, inadequate knowledge of its use may contribute to inappropriate anticoagulation. Instituto Nacional Cardiovascular - INCOR 2022-12-31 /pmc/articles/PMC10284579/ /pubmed/37351016 http://dx.doi.org/10.47487/apcyccv.v3i4.256 Text en https://creativecommons.org/licenses/by-nc/4.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons
spellingShingle Artículo Original
Vásquez Ortiz, Lady Rojana
Díaz Seijas, Deysi
Gordillo Campos, Natalia Emilia
Aguilar Alban, Ana Elizabeth
Conocimientos acerca del tratamiento con warfarina en pacientes con fibrilación auricular o portadores de válvulas protésicas mecánicas
title Conocimientos acerca del tratamiento con warfarina en pacientes con fibrilación auricular o portadores de válvulas protésicas mecánicas
title_full Conocimientos acerca del tratamiento con warfarina en pacientes con fibrilación auricular o portadores de válvulas protésicas mecánicas
title_fullStr Conocimientos acerca del tratamiento con warfarina en pacientes con fibrilación auricular o portadores de válvulas protésicas mecánicas
title_full_unstemmed Conocimientos acerca del tratamiento con warfarina en pacientes con fibrilación auricular o portadores de válvulas protésicas mecánicas
title_short Conocimientos acerca del tratamiento con warfarina en pacientes con fibrilación auricular o portadores de válvulas protésicas mecánicas
title_sort conocimientos acerca del tratamiento con warfarina en pacientes con fibrilación auricular o portadores de válvulas protésicas mecánicas
topic Artículo Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284579/
https://www.ncbi.nlm.nih.gov/pubmed/37351016
http://dx.doi.org/10.47487/apcyccv.v3i4.256
work_keys_str_mv AT vasquezortizladyrojana conocimientosacercadeltratamientoconwarfarinaenpacientesconfibrilacionauricularoportadoresdevalvulasprotesicasmecanicas
AT diazseijasdeysi conocimientosacercadeltratamientoconwarfarinaenpacientesconfibrilacionauricularoportadoresdevalvulasprotesicasmecanicas
AT gordillocamposnataliaemilia conocimientosacercadeltratamientoconwarfarinaenpacientesconfibrilacionauricularoportadoresdevalvulasprotesicasmecanicas
AT aguilaralbananaelizabeth conocimientosacercadeltratamientoconwarfarinaenpacientesconfibrilacionauricularoportadoresdevalvulasprotesicasmecanicas